Two-pronged Cell Therapy: Engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the adoptive imrnunotherapy of B-cell malignancies

被引:0
|
作者
Szoor, Arpad
Velasquez, Mireya Paulina
Bonifant, Challice Lee
Vaidya, Abishek
Brunetti, Lorenzo
Gundry, Michael
Parihar, Robin
Goodell, Margaret
Gottschalk, Stephen
机构
来源
JOURNAL OF IMMUNOLOGY | 2017年 / 198卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
198.6
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Two-Pronged Cell Therapy for B-Cell Malignancies: Engineering NK Cells to Target CD22 and Redirect Bystander T Cells to CD19
    Velasquez, Mireya Paulina
    Szoor, Arpad
    Bonifant, Challice L.
    Vaidya, Abishek
    Brunetti, Lorenzo
    Gundry, Michael C.
    Parihar, Robin
    Goodell, Margaret
    Gottschalk, Stephen
    BLOOD, 2016, 128 (22)
  • [2] Enhanced efficacy of CD19/CD22 bispecific CAR-T cells with EAAAK linker on B-cell malignancies
    Ma, Renyuxue
    You, Fengtao
    Tian, Shuaiyu
    Zhang, Tingting
    Tian, Xiaopeng
    Xiang, Shufen
    Wu, Hai
    Yang, Nan
    An, Gangli
    Yang, Lin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 64 - 74
  • [3] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
    Phely, Laurent
    Hensen, Luca
    Faul, Christoph
    Ruff, Christer Alexander
    Schneider, Dina
    Bethge, Wolfgang Andreas
    Lengerke, Claudia
    JAMA ONCOLOGY, 2024, 10 (06) : 821 - 824
  • [4] Receptor modulators of B-cell receptor signalling - CD19/CD22
    Smith, KGC
    Fearon, DT
    SIGNAL TRANSDUCTION AND THE COORDINATION OF B LYMPHOCYTE DEVELOPMENT AND FUNCTION I: TRANSDUCTION OF BCR SIGNALS FROM THE CELL MEMBRANE TO THE NUCLEUS, 2000, 245 : 195 - 212
  • [5] Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B-Cell Lymphoma Therapy
    Hong, Senlian
    Yu, Chenhua
    Wang, Peng
    Shi, Yujie
    Cao, Weiqian
    Cheng, Bo
    Chapla, Digantkumar G.
    Ma, Yuanhui
    Li, Jie
    Rodrigues, Emily
    Narimatsu, Yoshiki
    Yates, John R., III
    Chen, Xing
    Clausen, Henrik
    Moremen, Kelly W.
    Macauley, Matthew Scott
    Paulson, James C.
    Wu, Peng
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (07) : 3603 - 3610
  • [6] A New Class of Antigen T-Cells That Redirect Bystander T-Cells to CD19 Positive Malignancies
    Velasquez, Mireya Paulina
    Iwahori, Kota
    Kakarla, Sunitha
    Arber, Caroline
    Rodriguez-Cruz, Tania
    Gerken, Claudia
    Song, Xiao-Tong
    Gottschalk, Stephen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S71 - S71
  • [7] CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL
    Ghorashian, Sara
    Lucchini, Giovanna
    Richardson, Rachel
    Nguyen, Kyvi
    Terris, Craig
    Guvenel, Aleks
    Oporto-Espuelas, Macarena
    Yeung, Jenny
    Pinner, Danielle
    Chu, Jan
    Williams, Lindsey
    Ko, Ka-Yuk
    Walding, Chloe
    Watts, Kelly
    Inglott, Sarah
    Thomas, Rebecca
    Connor, Christopher
    Adams, Stuart
    Gravett, Emma
    Gilmour, Kimberly
    Lal, Alka
    Kunaseelan, Sangeetha
    Popova, Bilyana
    Lopes, Andre
    Ngai, Yenting
    Hackshaw, Allan
    Kokalaki, Evangelia
    Carulla, Milena Balasch
    Mullan, Khushnuma
    Lazareva, Arina
    Pavasovic, Vesna
    Rao, Anupama
    Bartram, Jack
    Vora, Ajay
    Chiesa, Robert
    Silva, Juliana
    Rao, Kanchan
    Bonney, Denise
    Wynn, Robert
    Pule, Martin
    Hough, Rachael
    Amrolia, Persis J.
    BLOOD, 2024, 143 (02) : 118 - 123
  • [8] CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
    Spiegel, Jay Y.
    Patel, Shabnum
    Muffly, Lori
    Hossain, Nasheed M.
    Oak, Jean
    Baird, John H.
    Frank, Matthew J.
    Shiraz, Parveen
    Sahaf, Bita
    Craig, Juliana
    Iglesias, Maria
    Younes, Sheren
    Natkunam, Yasodha
    Ozawa, Michael G.
    Yang, Eric
    Tamaresis, John
    Chinnasamy, Harshini
    Ehlinger, Zach
    Reynolds, Warren
    Lynn, Rachel
    Rotiroti, Maria Caterina
    Gkitsas, Nikolaos
    Arai, Sally
    Johnston, Laura
    Lowsky, Robert
    Majzner, Robbie G.
    Meyer, Everett
    Negrin, Robert S.
    Rezvani, Andrew R.
    Sidana, Surbhi
    Shizuru, Judith
    Weng, Wen-Kai
    Mullins, Chelsea
    Jacob, Allison
    Kirsch, Ilan
    Bazzano, Magali
    Zhou, Jing
    Mackay, Sean
    Bornheimer, Scott J.
    Schultz, Liora
    Ramakrishna, Sneha
    Davis, Kara L.
    Kong, Katherine A.
    Shah, Nirali N.
    Qin, Haiying
    Fry, Terry
    Feldman, Steven
    Mackall, Crystal L.
    Miklos, David B.
    NATURE MEDICINE, 2021, 27 (08) : 1419 - +
  • [9] DEVELOPMENT OF HUMAN B-CELL LINES DEFICIENT IN CD19, CD20, OR CD22
    WILSON, GL
    RIVA, A
    KEHRL, JH
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A99 - A99
  • [10] Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Liu, Sining
    Zhang, Xinyue
    Dai, Haiping
    Cui, Qingya
    Cui, Wei
    Yin, Jia
    Li, Zheng
    Xue, Shengli
    Yang, Chunxiu
    Yang, Xiao
    Qiu, Huiying
    Miao, Miao
    Chen, Suning
    Jin, Zhengming
    Fu, Chengcheng
    Li, Caixia
    Sun, Aining
    Han, Yue
    Wang, Ying
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2021, 138